Obscured bone metastases after administration of hematopoietic factor on FDG-PET

Clinical Nuclear Medicine

Volumn 31, Issue 6, 2006, Pages 328-330

  Chhabra, Avneesh ^a   Batra, Kiran ^a   Makler Jr , P Todd ^a  

^a HAHNEMANN UNIVERSITY HOSPITAL   (United States)

Author keywords

CT; FDG PET; Hypermetabolic; Metastasis; MRI

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ARTICLE; BONE MARROW; BONE METASTASIS; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; FEMALE; HUMAN; IMAGING; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY;

ARTIFACTS; BONE AND BONES; BONE NEOPLASMS; CHOLANGIOCARCINOMA; DIAGNOSTIC ERRORS; FALSE NEGATIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748128910     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000218575.91735.5f     Document Type: Article

References (11)

1. Chiang SB, Rebenstock A, Guan L, et al. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging. Clin Nucl Med. 2003;28:674.
2. Yeh CN, Chen MF, Chen TC, et al. Peripheral cholangiocarcinoma with thoracic spine metastasis: a successful surgically treated case. Int Surg. 2001;86:225.
3. Takahashi I, Nakamura Y, Suzuki Y, et al. Case report: bone metastasis from cholangiocarcinoma showing unusual accumulation on bone scintigraphy and 67Ga scintigraphy. Br J Radiol. 1994;67:303.
4. Kazama T, Faria SC, Varavithya V, et al. FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls. Radiographics. 2005;25:191.
5. Sugawara Y, Zasadny KR, Kison PV, et al. Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results. J Nucl Med. 1999;40:1456.
6. Hollinger EF, Alibazoglu H, Ali A, et al. Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clin Nucl Med. 1998;23:93.
7. Blodgett TM, Ames JT, Torok FS, et al. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin. Clin Nucl Med. 2004;29:161.
8. Abdel-Dayem HM, Rosen G, El-Zeftawy H, et al. Fluorine-18 fluorodeoxyglucose splenic uptake from extramedullary hematopoiesis after granulocyte colony-stimulating factor stimulation. Clin Nucl Med. 1999;24:319.
9. Elstrom RL, Tsai DE, Vergilio JA, et al. Enhanced marrow fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow. Clin Lymphoma. 2004;5:62.
10. Knoeller SM, Uhl M, Adler CP, et al. Differential diagnosis of benign tumors and tumor-like lesions in the spine. Own cases and review of the literature. Neoplasma. 2004;51:117.
11. Sugawara Y, Fisher SJ, Zasadny KR, et al. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol. 1998;16:173.